Henry S. Friedman

<i>IDH1</i>and<i>IDH2</i>Mutations in Gliomas

Hai Yan, D. Williams Parsons, Genglin Jin et al. · New England Journal of Medicine · 2009 · 5.9K citations · Full text

Medicine, Genetics, Oncology +16

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen et al. · Journal of Clinical Oncology · 2009 · 2.4K citations

Medicine, Oncology, Pharmacology +17

Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling

E Gluckman, HE Broxmeyer, Arleen D. Auerbach et al. · New England Journal of Medicine · 1989 · 2.1K citations

Life Sciences, Hematology, Immunology +16

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Journal of Clinical Oncology · 2007 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

Patrick Killela, Zachary J. Reitman, Yuchen Jiao et al. · Proceedings of the National Academy of Sciences · 2013 · 1.4K citations · Full text

Medicine, Genetics, Oncology +17